Investment objective

The Invesco Dynamic Pharmaceuticals ETF (Fund) is based on the Dynamic Pharmaceutical Intellidex Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Off-Hours Price
Change
YTD change
Weight
150.33USD-1.32%+42.82%5.27%
1,149.36USD-0.88%+6.95%5.03%
275.23USD-1.15%+32.99%5.01%
256.46USD-1.44%+12.24%4.99%
28.45USD-1.25%+14.26%4.94%
108.33USD-0.42%-13.54%4.93%
151.00USD-0.15%+23.02%4.9%
437.23USD-1.55%+33.58%4.9%
16.88USD-0.35%+35.58%3.28%
68.66USD+0.04%+99.07%3.18%
In partnership with
TrackInsight
Date Price Change Volume
04/09/26 $129.15 -0.34% 41,099
03/09/26 $129.59 -0.35% 69,342
02/09/26 $130.05 +1.58% 125,329
01/09/26 $128.02 +0.42% 79,011
31/08/26 $127.49 +0.18% 20,398

Description

US46137V6627
Total Expense Ratio 0.0057
Asset Class Stocks
Geographical Zones
Sector
Currency
Provider
Underlying Dynamic Pharmaceutical Intellidex Total Return Index - USD
Autres ETFs

Features and characteristics

Dividend Policy Distribution
Replication Method Physique
Jurisdiction
Date of creation
23/06/2005
Geographical Focus

Distribution

Retail investor

AuM evolution - 12/08/2026

AuM (USD) 592M
AuM 1M 592M
AuM 3 months 592M
AuM 6 months 592M
AuM 12 months 592M